Showing results (181-190 of 584) with videos related to

Sort By:
Pageof 59
JCO Precision Oncology|October 31, 2022
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine OncologyPatricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcomeAlice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
The Journal of Liquid Biopsy|March 3, 2025
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experienceClaudia Parisi, José Carlos Benitez, Hélène Lecourt, et al.
EJNMMI Research|August 1, 2020
18F-FDG PET and DCE kinetic modeling and their correlations in primary NSCLC: first voxel-wise correlative analysis of human simultaneous [18F]FDG PET-MRI dataFlorent L Besson, Brice Fernandez, Sylvain Faure, et al.
British Journal of Cancer|December 14, 2023
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trialSophie Postel-Vinay, Juan Coves, Matthieu Texier, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosisBenjamin Besse, Dominique Grunenwald, Aude Fléchon, et al.
Cancers|November 11, 2022
KRAS in NSCLC: State of the Art and Future PerspectivesPriscilla Cascetta, Arianna Marinello, Chiara Lazzari, et al.
Bulletin Du Cancer|March 7, 2006
[Cannabis and cancer]Stéphane Vignot, Benjamin Besse, Thibault de la Motte Rouge, et al.
The Lancet. Oncology|September 30, 2021
Late phase 1 studies: concepts and outcomesJose Carlos Benitez, Arthur Geraud, Matthieu Texier, et al.
Cancer Treatment Reviews|May 6, 2018
BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wallAlessandro Leonetti, Francesco Facchinetti, Giulio Rossi, et al.
Pageof 59